Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up

Published:2015-04-01 Issue:6 Volume:90 Page:515-523
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Mosna Federico¹,Papayannidis Cristina²,Martinelli Giovanni²,Di Bona Eros³,Bonalumi Angela⁴,Tecchio Cristina⁴,Candoni Anna⁵,Capelli Debora⁶,Piccin Andrea⁷,Forghieri Fabio⁸,Bigazzi Catia⁹,Visani Giuseppe¹⁰,Zambello Renato¹¹,Zanatta Lucia¹²,Volpato Francesca¹,Paolini Stefania²,Testoni Nicoletta²,Gherlinzoni Filippo¹,Gottardi Michele¹

Affiliation:

1. Department of Hematology; General Hospital; Treviso Italy

2. Department of Hematology; Ist “LA Seragnoli,” University of Bologna; Bologna Italy

3. Department of Hematology; General Hospital; Vicenza Italy

4. Department of Hematology; University of Verona; Verona Italy

5. Department of Hematology; University of Udine; Udine Italy

6. Department of Hematology; General Hospital; Ancona Italy

7. Department of Hematology; General Hospital; Bolzano Italy

8. Department of Hematology; University of Modena; Modena Italy

9. Department of Hematology; General Hospital; Ascoli-Piceno Italy

10. Department of Hematology; General Hospital; Pesaro Italy

11. Department of Hematology; University of Padova; Padova Italy

12. Department of Pathology; General Hospital; Treviso Italy

Publisher

Wiley

Subject

Hematology

Reference48 articles.

1. Core binding factor acute myeloid leukemia;Paschka;Semin Oncol,2008

2. Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: A Cancer and Leukemia Group B Study;Mrozek;J Clin Oncol,2001

3. Refinement of cytogenetic classification in acute myeloid leukemia: Determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials;Grimwade;Blood,2010

4. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): A Cancer and Leukemia Group B Study;Marcucci;J Clin Oncol,2005

5. Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: A SEER database analysis;Brunner;Leuk Res,2014

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT;Bone Marrow Transplantation;2024-08-20

2. Impact of measurable residual disease in combination with CD19 on postremission therapy choices for adult t(8;21) acute myeloid leukemia in first complete remission;Cancer Medicine;2024-02

3. Prevalence and Prognosis of Secondary Genetic Aberrations Among Patients With Core Binding Factor Acute Myeloid Leukemia: A Mitelman Database Analysis;World Journal of Oncology;2023-12

4. Therapy-related core binding factor acute myeloid leukemia;International Journal of Hematologic Oncology;2023-03

5. Case discussion: The critically ill older adult in spiritual distress;Geriatric Nursing;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3